SUMMARY The effects of glucose-insulin-potassium infusion (GIK) on atrial pacing-induced angina, ST depression, abnormal left ventricular end-diastolic pressure during pacing interruption (LVEDPi) and lactate metabolism (L), were studied in 18 patients: ten had angina during pacing = Ischemic group, and eight (5 normals and 3 with coronary artery disease) remained asymptomatic = Nonischemic group. The study consisted of 8-10 minute periods of control, pacing and recovery, before and after GIK. No untoward effects IN 1962 SODI-PALLARES' reported that the administration of glucose-insulin-potassium (GIK) was beneficial in the treatment of cardiac arrhythmias in the acute phase of myocardial infarction. This has become a highly controversial issue and reports both in favor and against this therapy have subsequently appeared in the literature. More recently, GIK has been found to decrease infarct size after coronary artery occlusion in dogs,2 9 but it has also been reported to be ineffective in increasing tolerance to pacing-induced myocardial ischemia. (GIK vs pre-GIK states) showed that during GIK, angina occurred in only 4 patients, while significantly less severe changes were observed in ST depression (1.4 ± 0.5 vs 2.4 ± 0.4 mm) and LVEDPi (16 ± 3 vs 23 ± 3 mm Hg). Lactate extraction was also higher (8.1 ± 10.9 vs -5.2 ± 11.1%), but not significantly so, although L became normal in 4 subjects and improved in another. These results indicate that GIK infusion was well tolerated and had a beneficial effect on pacing-induced myocardial ischenia.
IN 1962 SODI-PALLARES' reported that the administration of glucose-insulin-potassium (GIK) was beneficial in the treatment of cardiac arrhythmias in the acute phase of myocardial infarction. This has become a highly controversial issue and reports both in favor and against this therapy have subsequently appeared in the literature. More recently, GIK has been found to decrease infarct size after coronary artery occlusion in dogs,2 9 but it has also been reported to be ineffective in increasing tolerance to pacing-induced myocardial ischemia. 4 The objective of this preliminary study was to assess the influence of GIK on the pacinginduced myocardial ischemic syndrome which consists of chest pain, ST depression and abnormalities in left ventricular end-diastolic pressure and myocardial lactate extrac- tion. An abstract of this work has been published recently5 and our detailed observations constitute the basis of this report.
Methods
This study was performed in 18 patients referred for investigation of chest pain suspected to be due to coronary artery disease (table 1) . None of the patients had clinical diabetes mellitus, cardiac arrhythmias, cardiomegaly or cardiac failure and none was receiving digitalis or diuretics at the time of study. Informed consent was obtained in all subjects.
Patients were studied in the fasting state one hour after the oral administration of 10 mg of diazepam. Under local anesthesia the brachial artery and two veins were isolated in the right antecubital fossa. A number 8 Gorlin catheter was passed into the coronary sinus so the tip lay in its midposition. A number 7 or 8 Cournand catheter was advanced to the pulmonary artery. A number 8 Sones catheter was introduced into the right brachial artery and positioned in the left ventricle. A small Teflon catheter was inserted into the left brachial artery using the Seldinger technique. At the time of coronary sinus catheterization, 5000 i.u. of heparin were injected into the right atrium. During the remainder of the investigation, the arterial, left ventricular, pulmonary arterial and coronary sinus catheters were perfused with small volumes of normal saline containing 2 i.u. of heparin/ml at frequent intervals. The total fluid volume employed for this purpose did not exceed 100 ml.
Continuous recording of right and left heart pressures, brachial artery pressures and the electrocardiogram was carried out. Cardiac output was determined by the dye dilution technique between the fourth and eighth minute of each study period and the blood withdrawn for output determination was reinfused. Calculated variables were cardiac index (CI), left ventricular stroke work index (LVSWI) and a modified tension-time index (TTI), or the product of systolic blood pressure and heart rate. 6 The experimental protocol ( fig. 1 ) continued for 65 min. This consisted of a 10 min period of control, 8-10 min of pacing, and a 25 min period of recovery (recovery-control) followed by second pacing and recovery periods of 8-10 and 10 min duration, respectively. At the end of the first pacing period, the GIK solution (see below) was started intra- venously and continued for 45 min. This infusion was given during the three consecutive periods of recovery-control, pacing and recovery. Toward the end of each period, two paired blood samples (5 ml per sample) were taken from the brachial artery and coronary sinus (CS) for determination of glucose (G), lactate (L), free fatty acids (FFA) and inorganic phosphate (Pi). The total volume of blood for analysis was 50 ml.
Atrial pacing was accomplished with a Synchrocor II pacemaker via the Gorlin catheter. A constant rate was used throughout the pacing periods, and in any given patient the same rate was repeated during the second pacing stress. In the asymptomatic group, heart rates of approximately 140/min were selected. In those patients who developed angina, the pacing rate was chosen on the basis of exercise tolerance with the expectation of inducing chest pain between the fourth and sixth minute of pacing and maintaining it until pacing was discontinued between the eighth and tenth minute.
On the basis of selective coronary angiography, five patients were found to have normal coronary arteries while 13 had significant coronary atherosclerosis (75% or more narrowing of at least one major coronary artery). Ten of the CAD subjects with atrial pacing-induced angina pectoris are referred to as the ischemic group (I). The nonischemic group (NI) was composed of eight patients: the five normals and three subjects with coronary artery disease who had no symptoms during the pacing stress.
The GIK solution used was that initially recommended by Sodi-Pallares, and consisted of 500 ml of 10% glucose in water, 20 units of crystalline insulin and 40 mEq of KCI, and was infused into a central vein at a constant rate. At the end of the study, each patient had received 16.7 g of glucose, 6.7 U of insulin, and 13.3 mEq of KCI in a total volume of 166 ml.
Blood was collected in EDTA tubes, spun in a refrigerated centrifuge at 30 C and 3000 rpm within 15 min of sampling, and the plasma stored at -30°C. Chemical analyses were carried out using automated techniques with the Technicon Autoanalyzer. Lactate was determined by the fluorometric method of Apstein et al.7 which gave a coefficient of variation (CV) of 4.0% for N = 50. by the method of van Belle.'0 These methods had CV of 3.3% (N = 10) and 1 figure 3 . In the I group average blood glucose levels increased from 103 ± 2 to 163 ± 7 mg/dl (+58.3%, P < 0.001) and from 97 ± 2 to 140 ± 8 mg/dl in the NI group (+45.5%, P < 0.005). The highest blood glucose levels observed were 220 mg/dl and 180 mg/dl in the I and NI groups respectively. Mean arterial blood glucose levels were significantly higher in the I than in the NI group, at all times during the study.
Arterial blood lactate levels increased during GIK infusion from 7.2 ± 0.7 to 9.1 ± 0.7 mg/dl in the I group (+27.7%, P < 0.001) and from 6.3 ± 0.3 to 8.9 ± 0.6 mg/dl (+28.9%, P < 0.005) in the NI group. These levels were significantly higher in the I group only during the control-GIK period. Myocardial lactate uptake was moderately increased in both groups during the GIK infusion ( (table 7) . d) Lactate Metabolism. Mean lactate uptake before pacing was 27.1 ± 6.1% and decreased to an abnormal level of 8.1 ± 10.9 (P < 0.05). This value, however, was significantly better than that of -5.2 ± 11.1 (P < 0.025) seen during pacing before GIK. In the pre-GIK state lactate extraction was normal in three patients and abnormal in seven, with five of these being lactate producers. During the GIK infusion, the response to pacing stress in this group of seven patients, was also improved, with lactate extraction becoming normal in four and improved in one. The highest lactate production, seen in patients JG and JS, was not affected by the infusion (table 7) . In summary, it can be stated that with the exception of patient JG, every subject showed improvement or normalization of one or more of the components of the myocardial ischemic syndrome. JG had double vessel disease with decreased LV contractility and all abnormalities remained unchanged during GIK infusion. In view of the small numbers of patients in this group, no attempt was made to correlate severity of CAD with degree of improvement of the components of the ischemic syndrome. For other abbreviations see tables 1 and 2.
Discussion
The infusion of GIK was well tolerated by all patients in this study. There was no deterioration of any of the hemodynamic, electrocardiographic, or metabolic variables regardless of the severity of CAD. Two recent reports discuss the possible deleterious effect of GIK in patients with severe ischemic heart disease. Lesch and coworkers4 found that during GIK infusion tolerance to pacing-induced angina was diminished in five of eight patients, with occurrence of pulsus alternans, atrial fibrillation and ventricular extrasystoles. In addition, they observed that GIK infusion was associated with an elevation of LVEDP in all patients before pacing, and that in two subjects a further rise occurred during the pacing stress. None of these abnormal responses were seen in our study. This discrepancy cannot be readily explained although it may have been related to the presence of more severe CAD and higher blood sugar levels in their study than in ours. Delay in atrioventricular conduction (A-H interval) during atrial pacing has been reported by Gould et al.12 after the infusion of 50 g of glucose, 10 mEq of K, and 20 U of insulin over a 10-min period. This situation, however, is not comparable to that in our study where the GIK infusion was given at a much slower rate.
The infusion of GIK in the dose used in this study caused only modest increases in arterial blood glucose levels, with the highest value of 216 mg/dl occurring in one patient of the ischemic group. This rules out the possibility that changes in serum osmolality might have been responsible for the beneficial effects seen during pacing. The observation that blood glucose levels were significantly higher in the ischemic than in the nonischemic group, both before and during GIK infusion ( fig. 3) , may reflect subclinical diabetes mellitus in the ischemic group. In support of this assumption, there is evidence that asymptomatic hyperglycemia and glucose intolerance are associated with a higher incidence of coronary atherosclerosis.'3 Unfortunately, no information was available on the responses of these patients to standard glucose-loading tests.
The increase in arterial lactate levels and the fall in the arterial blood concentrations of FFA and Pi observed in our patients are considered to be part of the metabolic responses elicited by the GIK infusion. Insulin and hyperglycemia are known to promote the uptake and metabolism of glucose by the tissues, leading to acceleration of glycolysis and increased lactate production.14 In addition, this hormone is responsible for higher tissue uptake of Pi and inhibition of FFA release from fat depots. 15 The results of the present study show that, under the described experimental conditions, the infusion of GIK was capable of influencing favorably the components of the atrial pacing-induced ischemic syndrome. The discrepancy between our findings and those of Lesch and coworkers' cannot be readily explained and possible reasons for the differences between these two studies have been mentioned previously.
It could be argued that blood volume depletion was responsible for the improvement of angina during the GIK infusion, since it has been shown in our laboratory that phlebotomies ranging from 180 to 400 ml are beneficial in atrial pacing-induced myocardial ischemia. '8 However, in the present study, blood losses were small, and certainly not more than 60-70 ml, including 50 ml for chemical analyses, and not more than 10 ml were lost during the cut-down procedures and the insertion of the arterial cannula. These losses were more than counterbalanced by the administration of 166 ml of the GIK solution and the small amounts of saline used for flushing the intravascular lines, as described in the section on Methods. Therefore, it is unlikely that changes in blood volume were responsible for the less severe manifestations of the ischemic syndrome during the GIK state.
The use of GIK in man during the acute stages of myocardial infarction to prevent lethal arrhythmias and in congestive heart failure to improve pump function, has been reported with both favorable17 28 and unfavorable27-34 results. Some of the reasons for this controversy have been discussed elsewhere35' 38 and the human use of this therapeutic combination has been reviewed recently.37 3 Contrariwise, there is evidence that in the experimental canine myocardial infarction, GIK administration reduces significantly myocardial damage as reflected in less severe ST changes, depletion of myocardial CPK and glycogen, and electron microscopic changes2' 3 as well as by maintenance of cardiac output and stroke volume.'0 The discrepancy between the human and animal studies has been discussed by Braunwald and Maroko."1 It is not possible with our present knowledge to ascertain whether, in fact, the three components of the GIK solution are necessary to induce the beneficial response observed during pacing-induced ischemia. There is evidence that, in certain experimental situations, glucose, insulin and potassium are indeed beneficial to cardiac metabolism and performance. During hypoxia or ischemia, glucose has been shown to have a protective effect on the isolated perfused heart,42-" promoting an early and more complete recovery during reoxygenation, likely through preservation of high-energy compounds. It is known that during anoxia or ischemia the heart loses K+45' " and that loss of this cation inhibits mitochondrial respiration.'7 It is not surprising, therefore, that the presence of high K+ levels may reinforce the recuperative effect of glucose in the rat heart during the post-anoxic stage. 4 The addition of insulin to variable concentrations of glucose during anoxia results in significant increases in glucose utilization and left ventricular performance in the rat heart.48 This hormone is known to accelerate the uptake of glucose through a carrier-facilitated transport mechanism by inducing configurational changes in the plasma membrane, and also to increase the transfer of potassium from the extracellular to the intracellular compartment.'9 Considering the information reviewed above, it is not difficult to accept that the GIK combination is capable of having a beneficial influence on the human myocardium during reversible pacing-induced ischemia. These results, however, cannot be extended at this point to indicate that similar effects can be expected when this therapeutic combination is used in the acute stages of myocardial infarction in man. - The observation that GIK did not uniformly improve the ischemic syndrome in all patients is not surprising in view of the nature of CAD. It is known that the heterogeneous distribution of the arterial lesions and their various degrees of severity may account for the variability, not only of the clinical manifestations, but of the abnormal responses of the pacing-induced ischemic syndrome. GIK was unsuccessful in patient JG, who had DVD with good LV function on the ventriculogram. This patient, however, had severe CAD manifested by severe angina, the greatest ST depression (5 mm), the most abnormal LVEDP on pacing interruption (32 and 35 mm Hg), and the second highest myocardial lactate production (50 and 25%) in the ischemic group. It can be postulated that the location of the arterial lesions and the distribution of the coronary circulation was such as to prevent the GIK solution from reaching the ischemic areas.
The mechanism responsible for the beneficial effects of GIK on the pacing-induced ischemic syndrome remains speculative. Increased myocardial glucose uptake in the presence of insulin may have resulted in greater energy supply via enhanced anaerobic glycolysis or improved oxidative metabolism, although some of the glucose may have been directed also toward the synthesis of glycogen in the nonischemic myocardium. Furthermore, since data on coronary blood flow was not available in this study, the possibility that improved oxidative metabolism secondary to either increased total flow or redistribution of flow to the ischemic area cannot be clarified. These issues require further investigation.
